» Articles » PMID: 12414108

Histamine H1 Receptors in Rat Dorsal Raphe Nucleus: Pharmacological Characterisation and Linking to Increased Neuronal Activity

Overview
Journal Brain Res
Specialty Neurology
Date 2002 Nov 5
PMID 12414108
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In this work we studied the presence of histamine H(1) receptors in the rat dorsal raphe nucleus (DRN) and the effect of their activation on the activity of presumed serotonergic DRN neurones. [(3)H]-Mepyramine bound to DRN membranes with best-fit values of 107+/-13 fmol/mg protein for maximum binding (B(max)) and 1.2+/-0.4 nM for the equilibrium dissociation constant (K(d)). In DRN slices labelled with [(3)H]-inositol and in the presence of 10 mM LiCl, histamine stimulated the accumulation of [(3)H]-inositol phosphates ([(3)H]-IPs) with maximum effect 172+/-6% of basal and EC(50) 3.2+/-1.3 microM. [(3)H]-IPs accumulation induced by 100 microM histamine (162+/-5% of basal) was markedly, but not fully blocked by the selective H(1) antagonist mepyramine (300 nM; 64+/-6% inhibition). The simultaneous addition of mepyramine and the selective H(2) antagonist ranitidine (10 microM) abolished histamine-induced [(3)H]-IPs accumulation. The presence of H(2) receptors was confirmed by [(3)H]-tiotidine binding and by the determination of histamine-induced [(3)H]-cyclic AMP formation. Extracellular single-unit recording in brain stem slices showed that the exposure to histamine resulted in a marked increase in the firing rate of DRN presumed serotonergic neurones (471+/-10% of basal), that was dependent on the concentration of the agonist (EC(50) 4.5+/-0.3 microM). The action of histamine was not affected by the H(2) antagonist tiotidine (2 microM) but was fully prevented by 1 microM mepyramine. Taken together, our results indicate that histamine modulates the firing of DRN presumed serotonergic neurones through the activation of H(1) receptors coupled to phosphonositide hydrolysis.

Citing Articles

Histaminergic System and Vestibular Function in Normal and Pathological Conditions.

Tighilet B, Trico J, Marouane E, Zwergal A, Chabbert C Curr Neuropharmacol. 2024; 22(11):1826-1845.

PMID: 38504566 PMC: 11284731. DOI: 10.2174/1570159X22666240319123151.


Inhibition of Astrocytic Histamine -Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease.

Flores-Clemente C, Nicolas-Vazquez M, Mera Jimenez E, Hernandez-Rodriguez M Biomolecules. 2021; 11(10).

PMID: 34680041 PMC: 8533269. DOI: 10.3390/biom11101408.


A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.

Provensi G, Costa A, Rani B, Blandina P, Passani M Curr Top Behav Neurosci. 2021; 59:389-410.

PMID: 34410679 DOI: 10.1007/7854_2021_236.


Inactivation of the Tuberomammillary Nucleus by GABA Receptor Agonist Promotes Slow Wave Sleep in Freely Moving Rats and Histamine-Treated Rats.

Xie J, Fan K, Wang C, Xie P, Hou M, Xin L Neurochem Res. 2017; 42(8):2314-2325.

PMID: 28365867 DOI: 10.1007/s11064-017-2247-3.


Evidence for a histaminergic input from the ventral tuberomammillary nucleus to the solitary tract nucleus involved in arterial pressure regulation.

Yamanaka K, Gouraud S, Takagishi M, Kohsaka A, Maeda M, Waki H Physiol Rep. 2017; 5(5).

PMID: 28292881 PMC: 5350161. DOI: 10.14814/phy2.13095.